Pennsylvania’s Eligibility Requirements
Annette Folgueras MD » Medical Marijuana in Pennsylvania
Residents of Pennsylvania who have a serious medical condition as certified by a Marijuana Doctor are considered medical marijuana patients. A patient must obtain a medical marijuana ID card to purchase medical marijuana at a dispensary in Pennsylvania. Caregivers should also reside in Pennsylvania and be designated by patients to deliver medical marijuana obtained at a Pennsylvania dispensary. The caregiver must register for an ID card and complete a background check.
Participating in the program
Frequently Asked Questions
How much is the medical marijuana ID card?
The fee for the patient or caregiver’s medical marijuana ID card is $50. Individuals who participate in the following government programs may qualify for a discounted medical marijuana ID card: Medicaid, PACE/ PACENET, CHIP, SNAP, and WIC.
Can you register as a patient for the program if you have a criminal record?
Can minors with serious medical conditions get medical marijuana?
Who can participate in this program?
Please follow these four steps in order to get your medical marijuana card:
- Register on the PA Department of Health website
- Schedule an appointment with Dr. Folgueras and get certified;
- Pay the state for your medical marijuana ID card
- Bring your medical marijuana ID card to a Pennsylvania medical dispensary.
What info do I need and how do I register for my medical card?
We are here to help so don’t hesitate to call.
Do you have any tips for a successful registration?
Your name must match. Your address is recognized by the USPS as a valid mailing address. We are here to help so don’t hesitate to call.
What are the approved "serious medical conditions"?
- Amyotrophic lateral sclerosis (ALS);
- Anxiety disorders;
- Autism;
- Cancer, including remission therapy;
- Crohn’s disease;
- Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies;
- Dyskinetic and spastic movement disorders;
- Epilepsy;
- Glaucoma;
- HIV / AIDS;
- Huntington’s disease;
- Inflammatory bowel disease;
- Intractable seizures;
- Multiple sclerosis;
- Neurodegenerative diseases;
- Neuropathies;
- Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjunctive therapy is indicated in combination with primary therapeutic interventions;
- Parkinson’s disease;
- Post-traumatic stress disorder;
- Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain;
- Sickle cell anemia;
- Terminal illness; and
- Tourette syndrome.